2009 Fiscal Year Final Research Report
The roles of chemical mediators in the pathogenesis of psoriasis vulgaris and their therapeutical application
Project/Area Number |
18591259
|
Research Category |
Grant-in-Aid for Scientific Research (C)
|
Allocation Type | Single-year Grants |
Section | 一般 |
Research Field |
Dermatology
|
Research Institution | Teikyo University |
Principal Investigator |
KANDA Naoko Teikyo University, 医学部, 准教授 (50260493)
|
Co-Investigator(Kenkyū-buntansha) |
WATANABE Shinichi 帝京大学, 医学部, 教授 (90114719)
ONISHI Takamitsu 帝京大学, 医学部, 准教授 (80233211)
TADA Yayoi 東京大学, 医学部附属病院, 講師 (00334409)
|
Project Period (FY) |
2006 – 2009
|
Keywords | 尋常性乾癬 / ケミカルメディエーター / ケラチノサイト |
Research Abstract |
Psoriasis vulgaris is an autoimmune inflammatory dermatosis. Chemical mediators may be involved in the pathogenesis of this disease. Prolactin acts on keratinocytes and induces their production of CXCL9/10/11 or CCL20 chemoattracting Th1/Tc1 cells or Th17 cells, respectively. Leukotriene B_4 acts on keratinocytes and induces their production of CCL27 chemoattracting skin-homing memory T cells. These mediators may induce the infiltration of T cells into psoriatic skin lesions via these chemokines. Leptin induces the production of antimicrobial peptide human β-defensin-2, and histamine induces human β-defensin-2 and human β-defensin-3 production in keratinocytes. These mediators may enhance the proliferation of keratinocytes, angiogenesis, and infiltration of Th17 cells in psoriatic skin lesions in addition to the enhancement of cutaneous antimicrobial activities.
|
Research Products
(18 results)
-
[Journal Article] Prolactin enhances basal and IL-17-induced CCL20 production by human keratinocytes.2009
Author(s)
Kanda, N., Shibata, S., Tada, Y., Nashiro, K., Tamaki, K., Watanabe, S.
-
Journal Title
Eur J Immunol 39
Pages: 996-1006
Peer Reviewed
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-